The List of Medicinal Products Mark-ups on Which Are Regulated by State

On March 16^th, 2017, the Government adopted Resolution “On Amendments to and Recognition of Certain Decisions of the Cabinet of Ministers of Ukraine Expired” No. 180 which, in particular, amended Resolution of the Cabinet of Ministers of Ukraine “Some Issues of State Regulation of Prices for Medicinal Products and Medical Devices” No. 333 as of March 25^th, 2009.

This regulatory act approved a new version of the National List of Essential Medicines (hereinafter - the National List), formed on the basis of the WHO Model List of Essential Medicines, which became effective on March 25^th, 2017.

The new National List contains about 350 INPN, indicating the forms of release and dosage.

We draw your attention to the fact that in accordance with Resolution of the Cabinet of Ministers “On Measures to Stabilize Prices for Medicinal Products and Medical Devices” No. 955 as of October 17^th, 2008, medicinal products included in the National List (except for narcotic drugs, psychotropic drugs, precursors and medical gases) are subject to state price regulation. Namely, maximum supply-and-marketing mark-ups not exceeding 10% were set, which accrue on the ex-factory price, including taxes and duties, and the maximum trade (retail) mark-ups not exceeding 25%, accruing on the purchase price including taxes were set.

Thus, business entities engaged in wholesale and retail trade in medicinal products need to analyze the new National List within the next few days and conduct recalculation in accordance with the requirements of the legislation in the area of pricing.